Posted July 1, 2009
NanoCor Therapeutics raises $2.5M
Post a comment
Print this storyE-mail story
Share
Chapel Hill, N.C. —
Drug startup NanoCor Therapeutics has closed on $2.5 million in new financing.
Medtronic, a medical technology company based in Minnesota, made the investment. It pledged to invest $7.5 million in NanoCor two years ago.
NanoCor is developing a treatment for congestive heart failure. It is utilizing technology developed at UNC-Chapel Hill.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
